Braveheart Bio jumps 68% in trading debut after $383M IPO
Braveheart Bio's IPO success highlights strong investor appetite for biotech innovation, despite risks of high valuations without revenue.
The post Braveheart Bio jumps 68% in trading debut after $383M IPO appeared first on Crypto Briefing.
This content is automatically aggregated. Full credit goes to the original publisher (cryptobriefing.com).
